CN108892608A - The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet - Google Patents

The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet Download PDF

Info

Publication number
CN108892608A
CN108892608A CN201811107415.3A CN201811107415A CN108892608A CN 108892608 A CN108892608 A CN 108892608A CN 201811107415 A CN201811107415 A CN 201811107415A CN 108892608 A CN108892608 A CN 108892608A
Authority
CN
China
Prior art keywords
zerumbone
rhizoma zingiberis
volatile oil
reference substance
zingiberis zerumbet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811107415.3A
Other languages
Chinese (zh)
Inventor
田民义
周英
吴相欢
洪怡
林冰
邓国栋
刘雄利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guizhou University
Original Assignee
Guizhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guizhou University filed Critical Guizhou University
Priority to CN201811107415.3A priority Critical patent/CN108892608A/en
Publication of CN108892608A publication Critical patent/CN108892608A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/81Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C07C45/82Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation
    • C07C45/84Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation by azeotropic distillation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/81Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N30/14Preparation by elimination of some components
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N2030/042Standards
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N2030/062Preparation extracting sample from raw material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a kind of preparation methods of zerumbone reference substance in Rhizoma Zingiberis zerumbet, the present invention is using fresh Rhizoma Zingiberis zerumbet underground rhizome as raw material, extract volatile oil, zerumbone reference substance is prepared by recrystallization method, the zerumbone sterling of prepared acquisition, it is detected through HPLC, it is a mass-tone spectral peak in different mobile phases and chromatographic column measurement result, change mobile phase and chromatographic column measurement does not occur anomaly peak, it is greater than 99% with area normalization method measurement reference substance purity, meets the requirement of assay traditional Chinese chemical contrast.

Description

The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet
Technical field
The present invention relates to a kind of separating and purifying technologies, especially using fresh Rhizoma Zingiberis zerumbet underground rhizome as raw material, extract volatilization Oil, the method that zerumbone reference substance is prepared by recrystallization.
Background technique
Rhizoma Zingiberis zerumbet (Zingiber zerumbet (L.) Smith) is Zingiber zingiber herbaceos perennial.It is i.e. pharmaceutically acceptable, Again edible, underground rhizome can be used as appetizer and food dressing.According to《Guangxi plant register》It records, the rhizome of Rhizoma Zingiberis zerumbet Detoxify with wind-dispelling, control collywobbles, the function of diarrhea, modern pharmacology research shows that Rhizoma Zingiberis zerumbet has antitumor, anti-inflammatory, antioxygen The pharmacological actions such as change, antiallergy, antimicrobial, antihyperglycemic and analgesia.
Primary pharmacological activity ingredient of the zerumbone as Rhizoma Zingiberis zerumbet, belongs to sesquiterpenoids.Domestic and foreign literature report Show zerumbone have anti-malignant tumor activity, anti-inflammatory activity, antibacterial activity, anti-osteoporosis activity and hepatoprotective effect, Analgesic activity and improvement diabetes effect.Current study show that potential candidate of the zerumbone as anticancer drug, has wide Application prospect.Therefore, the zerumbone reference substance of high-purity how is prepared, needs solve.
Summary of the invention
Technical problem to be solved by the invention is to provide a kind of preparation methods of zerumbone reference substance in Rhizoma Zingiberis zerumbet, with new Fresh Rhizoma Zingiberis zerumbet underground rhizome is raw material, extracts volatile oil, prepares zerumbone reference substance by recrystallization, it can be from Rhizoma Zingiberis zerumbet Separation obtains the zerumbone of very high purity.
The invention is realized in this way:Using fresh Rhizoma Zingiberis zerumbet underground rhizome as raw material, volatile oil is extracted, by recrystallization side Method prepares zerumbone reference substance, comprises the technical steps that:
(1) extraction of Rhizoma Zingiberis zerumbet volatile oil:Fresh Rhizoma Zingiberis zerumbet underground rhizome is crushed, raw material and distilled water are pressed 1:2-1: 5 solid-liquid ratio, extracts 2h-6h in volatile oil extractor, through n-hexane extraction, filters after being removed water with anhydrous sodium sulfate, decompression Concentration obtains Rhizoma Zingiberis zerumbet volatile oil after removing n-hexane;
(2) recrystallization isolates and purifies to obtain zerumbone reference substance:To be added n-hexane in Rhizoma Zingiberis zerumbet volatile oil, volatile oil with The solid-liquid ratio of n-hexane is 2:1-1:2, after heating for dissolving, 5min-30min is recrystallized at -22 DEG C, filters to obtain zerumbone crystal Crude product;N-hexane will be added in zerumbone crystal crude product again, the solid-liquid ratio of volatile oil and n-hexane is 2:1-1:2, it dissolves by heating Afterwards, 5min-20min is recrystallized at -22 DEG C, is filtered, and the zerumbone sterling that purity is 99% or more is obtained.
In order to further verify technical effect of the invention, following experiment has been carried out:
The separation of 1 zerumbone monomeric compound
The extraction of 1.1 Rhizoma Zingiberis zerumbet volatile oil
Fresh Rhizoma Zingiberis zerumbet underground rhizome 500g is weighed, after crushing, is placed in 2L round-bottomed flask, several beades and steaming is added Distilled water 1000mL after stirring evenly, is placed in electric jacket, connects volatile oil extractor.Distilled water is added from the upper end of condenser pipe, until Distilled water is until overflow enters round-bottomed flask from determination of volatile oil pipe.Heating keeps slightly boiled 4h.By in extractor water and volatilization It is oily to release, it is concentrated under reduced pressure after removing n-hexane with being filtered after the water removal of appropriate anhydrous sodium sulfate through appropriate n-hexane extraction and is obtained Rhizoma Zingiberis zerumbet Volatile oil obtains volatile oil 0.51g.
The 1.2 isolated zerumbone reference substances of recrystallization
The n-hexane of 0.3mL is added in Rhizoma Zingiberis zerumbet volatile oil, shakes up dissolution in 40 DEG C of heating, is refrigerated at -22 DEG C 15min after precipitating crystal, filters to obtain zerumbone crystal crude product;0.2mL n-hexane will be added in zerumbone crystal crude product again, 40 DEG C of heating shake up dissolution, and 10min is refrigerated at -22 DEG C, filter, and obtain the zerumbone sterling 0.32g that purity is 99% or more. Through MS,1H-NMR,13C-NMR is measured confirmation.
1.3 conclusion
By MS,1H-NMR,13C-NMR is measured, and is determined as zerumbone.EI-MS determination data shows and composes in library Zerumbone Data Matching;1H-NMR,13C-NMR is consistent with document zerumbone data.EI-MS m/z (%):218 [M+], 203, 189,175,163,150,135 (100), 121,107,96,79,67,53,41.1H-NMR(CDCl3, 400MHz), δ:5.96- 5.92 (1H, m, H-6), 5.89 (1H, d, J=16.4Hz, H-9), 5.78 (1H, d, J=16.4Hz, H-10), 5.18 (1H, bd, J=15.1Hz, H-2), 2.43-2.30 (1H, m, H-5), 2.30-2.12 (4H, m, H-1, H-4, H-5), 1.88-1.75 (1H, M, H-1), 1.72 (3H, s, H-13), 1.46 (3H, s, H-12), 1.13 (3H, s, H-14), 0.99 (3H, s, H-15);13C-NMR (CDCl3, 100MHz), δ:42.4 (C-1), 125.0 (C-2), 136.3 (C-3), 39.5 (C-4), 24.5 (C-5), 148.9 (C- 6), 137.9 (C-7), 204.3 (C-8), 127.2 (C-9), 160.7 (C-10), 37.9 (C-11), 15.3 (C-12), 11.8 (C- 13), 29.5 (C-14), 24.3 (C-15).As a result as shown in Fig. 3, Fig. 4 and Fig. 5.
The purity detecting of 2 zerumbone reference substances
2.1 high performance liquid chromatographies-purity test
Using Agilent 1260 type high performance liquid chromatograph (quaternary pump, column oven, autosampler, DAD ultraviolet detection Device, ChemStation chromatographic work station), with Agilent company ZORBAX SB-C18 (4.6 × 250mm, 5 μm) chromatographic column, column 48 DEG C of temperature, mobile phase are -0.25% acetic acid (70 of acetonitrile:30), DAD sets wave-length coverage as 200~400nm, setting 240, 260,280, five 290,310nm Detection wavelengths, and the detection case of other wavelength is observed simultaneously, to investigate the pure of zerumbone Degree.
Using acetonitrile as solvent, zerumbone is configured to the solution of every 1.5mg/mL, as test solution, takes blank solvent Each 10 μ L of (acetonitrile) and test solution, is injected separately into liquid chromatograph, after as a result deducting the chromatographic peak that blank solvent generates, ball The chromatographic peak area normalization content of zingiberone is all larger than 99% or more under each wavelength, is shown in Table 1, Fig. 6 and Fig. 7.
The measurement result of each wavelength of 1 zerumbone of table
2.2 mobile phases are investigated
Zerumbone test liquid is taken, uses -0.25% acetic acid (70 of acetonitrile respectively:30), -0.05% formic acid (80 of methanol:20), second Nitrile-methanol-water (60:15:25), acetonitrile-water (80:20), methanol-water (80:20) it is mobile phase, obtains HPLC map, as a result Show do not occur anomaly peak under the conditions of each mobile phase, remove solvent peak, under the conditions of each mobile phase of area normalization method measurement The content of zerumbone is all larger than 99%.It the results are shown in Table 2, Fig. 8-12.
2 mobile phase result of study of table
The investigation of 2.3 pillars
Zerumbone test liquid is taken, uses Agilent company ZORBAX SB-C18 (4.6 × 250mm, 5 μm) chromatography respectively Column, Shimadzu Corporation Wonda Cract ODS-2 (4.6 × 250mm, 5 μm) chromatographic column, Agilent company Eclipse XDB-C18 (4.6 × 250mm, 5 μm) chromatographic column, obtains HPLC map, the results showed that changes chromatographic column and does not occur anomaly peak, removes solvent Peak, with area normalization method measure the content of ar-turmerone is all larger than 99%.It the results are shown in Table 3, Figure 13-15.
3 chromatographic column result of study of table
By adopting the above-described technical solution, the present invention is a kind of using fresh Rhizoma Zingiberis zerumbet underground rhizome as raw material, raw material is mentioned After taking volatile oil, zerumbone reference substance is prepared by recrystallization method, the zerumbone sterling of prepared acquisition is detected through HPLC, Be a mass-tone spectral peak in different chromatographic columns and mobile phase measurement result, change chromatographic column and mobile phase measurement do not occur it is different Chang Feng removes solvent peak, is greater than 99% with area normalization method measurement reference substance purity, meets assay Chemistry for Chinese Traditional Medicine pair According to the requirement of product.
Detailed description of the invention
Fig. 1 is the HPLC testing result of the product of the embodiment of the present invention;
Fig. 2 is the GC-MS result of dry and fresh Rhizoma Zingiberis zerumbet rhizome volatile oil;
Fig. 3 is zerumbone mass spectrum EI of the invention;
Fig. 4 is zerumbone of the invention1H-NMR;
Fig. 5 is zerumbone of the invention13C-NMR;
Fig. 6 is the blank solvent HPLC map under 5 wavelength;
Fig. 7 is the HPLC map of the zerumbone measured under 5 wavelength;
Fig. 8 is -0.25% acetic acid (70 of acetonitrile:30) the HPLC map of test solution and blank solvent;
Fig. 9 is -0.05% formic acid (80 of methanol:20) the HPLC map of test solution and blank solvent;
Figure 10 is acetonitrile-methanol-water (60:15:25) the HPLC map of test solution and blank solvent;
Figure 11 is acetonitrile-water (80:20) the HPLC map of test solution and blank solvent;
Figure 12 is methanol-water (80:20) the HPLC map of test solution and blank solvent;
Figure 13 is the HPLC map of Agilent ZORBAX SB-C18 (4.6 × 250mm, 5 μm) chromatographic column;
Figure 14 is the HPLC map of Shimadzu Wonda Cract ODS-2 (4.6 × 250mm, 5 μm) chromatographic column;
Figure 15 is the HPLC map of Agilent Eclipse XDB-C18 (4.6 × 250mm, 5 μm) chromatographic column.
Specific embodiment
The embodiment of the present invention:The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet is with fresh Rhizoma Zingiberis zerumbet underground rhizome Raw material extracts volatile oil, prepares zerumbone reference substance by recrystallization method, comprise the technical steps that:
(1) extraction of Rhizoma Zingiberis zerumbet volatile oil:By fresh Rhizoma Zingiberis zerumbet underground rhizome 500g, after crushing, it is placed in 2L round-bottomed flask In, by medicinal material and distilled water 1:Distilled water 1000mL is added in 2 solid-liquid ratio, volatile oil extractor is connected, in determination of volatile oil Appropriate distilled water is added in pipe, and slightly boiled heating 4h collects the water and volatile oil in extractor, through n-hexane extraction, with appropriate anhydrous It is filtered after sodium sulphate water removal, is concentrated under reduced pressure after removing n-hexane and obtains Rhizoma Zingiberis zerumbet volatile oil 0.51g.
(2) isolated zerumbone reference substance is recrystallized:In Rhizoma Zingiberis zerumbet volatile oil, the n-hexane of 0.3mL is added, 40 It is dissolved by heating in DEG C water-bath, is placed at 15min in -22 DEG C of refrigerators, after precipitating crystal, filters to obtain zerumbone crystal crude product;Again 0.2mL n-hexane is added in zingiberone crystal crude product, is dissolved by heating in 40 DEG C of water-baths, it is lower in -22 DEG C of refrigerators to stand 10min is filtered, and obtains the zerumbone sterling 0.32g that purity is 99% or more.
By the zerumbone sterling of acquisition, detected by HPLC, using acetonitrile and 0.25% acetic acid aqueous solution as mobile phase, acetonitrile Volume with 0.25% acetic acid aqueous solution is 70:30, column temperature is 48 DEG C, flow velocity 1mL/min, Detection wavelength 280nm, chromatography Column is Shimadzu Wonda Cract ODS-2 (4.6 × 250mm, 5 μm), and testing result is as shown in Figure 1, purity is 100.00%.
Currently, Rhizoma Zingiberis zerumbet underground rhizome is all after drying as Chinese medicine.But the present invention is with choosing fresh Rhizoma Zingiberis zerumbet Lower rhizome is raw material, is because the content of zerumbone largely reduces after inventor's discovery Rhizoma Zingiberis zerumbet rhizome drying.Pass through GC-MS Zerumbone content is measured in the volatile oil extracted to Rhizoma Zingiberis zerumbet rhizome, the results showed that:Fresh content is 70.23%, is done Dry content is 37.39%.After Rhizoma Zingiberis zerumbet rhizome is dry, the content of zerumbone is largely reduced, and as a result sees Fig. 2.

Claims (2)

1. the preparation method of zerumbone reference substance in a kind of Rhizoma Zingiberis zerumbet, it is characterised in that:It is original with fresh Rhizoma Zingiberis zerumbet underground rhizome Material extracts volatile oil, prepares zerumbone reference substance by recrystallization method.
2. the preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet according to claim 1, it is characterised in that:Including following work Skill step:
(1) extraction of Rhizoma Zingiberis zerumbet volatile oil:Fresh Rhizoma Zingiberis zerumbet underground rhizome is crushed, the raw material of crushing and distilled water are pressed 1:2- 1:5 solid-liquid ratio mixing, unit g/ml, after mixed material is extracted 2-6h in volatile oil extractor, volatile oil is through n-hexane Extraction, is filtered after being removed water with anhydrous sodium sulfate, obtains Rhizoma Zingiberis zerumbet volatile oil after removing n-hexane using reduced pressure;
(2) recrystallization isolates and purifies to obtain zerumbone reference substance:To be added n-hexane in Rhizoma Zingiberis zerumbet volatile oil, volatile oil with just oneself The volume ratio of alkane is 2:1-1:2, it is heated to after being completely dissolved, recrystallizes 5-30min at -30~-15 DEG C, filter to obtain zerumbone Crystal crude product;N-hexane will be added in zerumbone crystal crude product again, the volume ratio of zerumbone crystal crude product and n-hexane is 2:1- 1:2, it is heated to after being completely dissolved, 5-20min is recrystallized at -30~-15 DEG C, filter, obtain the ball that purity is 99% or more Zingiberone sterling.
CN201811107415.3A 2018-09-21 2018-09-21 The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet Pending CN108892608A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811107415.3A CN108892608A (en) 2018-09-21 2018-09-21 The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811107415.3A CN108892608A (en) 2018-09-21 2018-09-21 The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet

Publications (1)

Publication Number Publication Date
CN108892608A true CN108892608A (en) 2018-11-27

Family

ID=64359513

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811107415.3A Pending CN108892608A (en) 2018-09-21 2018-09-21 The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet

Country Status (1)

Country Link
CN (1) CN108892608A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002155001A (en) * 2000-11-17 2002-05-28 Japan Science & Technology Corp Perfume substance comprising derivative of zerumbone
CN101068559A (en) * 2004-07-23 2007-11-07 林忠宗 Anti-hypersensitive inflammation and anti-allergy activities of zingiber zerumbet (L.) smith
US20090239953A1 (en) * 2006-11-21 2009-09-24 Adel Sharaf Al-Zubairi Use of an anti-cancer compound
BRPI1003607A2 (en) * 2010-09-23 2013-01-08 Inst Nac De Pesquisas Da Amazonia Inpa pharmaceutical composition comprising zingiber zerumbet extract and pain reduction process
WO2014123406A1 (en) * 2013-02-06 2014-08-14 Universiti Putra Malaysia A composition for treating leukemia

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002155001A (en) * 2000-11-17 2002-05-28 Japan Science & Technology Corp Perfume substance comprising derivative of zerumbone
CN101068559A (en) * 2004-07-23 2007-11-07 林忠宗 Anti-hypersensitive inflammation and anti-allergy activities of zingiber zerumbet (L.) smith
US20090239953A1 (en) * 2006-11-21 2009-09-24 Adel Sharaf Al-Zubairi Use of an anti-cancer compound
BRPI1003607A2 (en) * 2010-09-23 2013-01-08 Inst Nac De Pesquisas Da Amazonia Inpa pharmaceutical composition comprising zingiber zerumbet extract and pain reduction process
WO2014123406A1 (en) * 2013-02-06 2014-08-14 Universiti Putra Malaysia A composition for treating leukemia

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
M.R.SULAIMAN等: "Preliminary analysis of the antinociceptive activity of zerumbone", 《FITOTERAPIA》 *
NUR FARHANAH MOHAMAD NOOR等: "Isolation, characterization and modification of zerumbone from Zingiber zerumbet", 《EPROCEEDINGS CHEMISTRY》 *
WU YAN等: "Contact and Repellant Activities of Zerumbone and Its Analogues from the Essential Oil of Zingiber zerumbet (L.) Smith against Lasioderma serricorne", 《JOURNAL OF OLEO SCIENCE》 *

Similar Documents

Publication Publication Date Title
Ma et al. One step isolation and purification of liquiritigenin and isoliquiritigenin from Glycyrrhiza uralensis Risch. using high-speed counter-current chromatography
CN102976909B (en) Method for extracting and purifying 6-gingerol from ginger
CN104861019B (en) The method that high speed adverse current chromatogram prepares flavone compound 1,2 in tea seed shell
CN105399656A (en) Isobenzazole alkaloid compound, and preparation method and applications thereof
CN102351824A (en) Method for preparing lactuca indica and lactucin
CN104447673B (en) Chinese fiber crops compound and its separation method
CN105348192A (en) Antiviral-activity isoquinoline alkaloid compound in Cassia alata L. and preparation method of antiviral-activity isoquinoline alkaloid compound
CN101255182B (en) Extraction separating method for bupleurum root saponin b2
CN104606184B (en) The inflammatory applications and its extracting method of the not fragrant lactone of 7 (11) alkene 12,8 of 6 hydroxyl Airies in Radix Ligulariae Dentatae
CN107298642B (en) Extraction and purification method of 6-shogaol
CN109320571A (en) The method for extracting luteolin kind compound and cynaropicrin
CN101830892A (en) Method for separating glycoside chemical components from tibetan capillaris
CN108892608A (en) The preparation method of zerumbone reference substance in Rhizoma Zingiberis zerumbet
CN101845037B (en) Method for separating xanthione chemical component in Swertia mussoti
CN101323605B (en) Preparation of isobenzofuran ketone compounds
CN105384784B (en) The screening of three kinds of antioxidation activity 2,3,5,4'-tetrahydroxyl diphenylethylene-2-O-BETA-D-glucoside class materials, method for separating and preparing in the Qinghai cultivation fleece-flower root
CN107383129B (en) A kind of tonka bean camphor glycosides compounds and its preparation method and application
CN102786505B (en) Preparation method for separating three flavone monomeric compounds from flos pedicularis
CN106674239B (en) A kind of Viburnum opulus Linn. var. calvescens (Rehd.) Hara f. calvescens branches and leaves lignanoid and extracting method and purposes
CN104592322A (en) Method for extracting and separating curculigoside from curculigo gaertn plants
CN103880895A (en) Method for preparing harpagoside and sibirioside A by using high-speed counter-current chromatography through separation and purification
CN101225095A (en) Method for extracting aucubin from pedicularis plants
CN109206392B (en) Coumarin compound and preparation method and application thereof
CN108084241B (en) The method that separation prepares fucosterol from sargassum fusifome
CN107074798B (en) Method for extracting phytoxin from rhodiola rosea

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181127

RJ01 Rejection of invention patent application after publication